VORVIDA® for alcohol use reduction

Short facts



GAIA´s proprietary artificial intelligence (AI)-expert system, broca®


Heavy alcohol use

Period for use

6 months

Commercial rights

Orexo owns the exclusive rights to the US market


In-licensed from 


July, 2020, in the US

Key advantages

• Based on Cognitive Behavioral Therapy
• Strong clinical evidence
• Highly individualized

The Concept/Product

VORVIDA® is a fully automated digital program developed by Orexo´s partner GAIA and is based on its proprietary artificial intelligence (AI)-expert system, broca®. VORVIDA® is scientifically proven to reduce troublesome drinking patterns in adults.

Clinical Data

In a randomized controlled trial involving 608 adults with problematic alcohol intake, researchers found that participants in the intervention group with VORVIAD® significantly reduced their daily alcohol consumption over three and six months, with significant effect sizes.1 Additionally, in comparison to the control group, VORVIDA® users reported fewer days of binge drinking and drunkenness while stating high acceptance and utility rates of VORVIDA® at the same time.

1 Jördis M. Zill, Eva Christalle, Björn Meyer, Martin Härter, and Jörg Dirmaier The Effectiveness of an Internet Intervention Aimed at Reducing Alcohol Consumption in Adults: Results of a Randomized Controlled Trial (Vorvida) Dtsch Arztebl Int 2019; 116: 127–33. DOI: 10.3238/arztebl.2019.0127